Literature DB >> 885298

Relationship of microvascular disease in diabetes to metabolic control.

R Engerman, J M Bloodworth, S Nelson.   

Abstract

Dogs were made alloxan-diabetic and randomly distributed into either of two prospective treatment groups. In one group it was intended that the metabolic signs of diabetes be controlled poorly, and commercial insulin was administered in doses inadequate to prevent chronic, severe hyperglycemia and glucosuria. In the other group it was intended that the metabolic disorder be well controlled, and the animals received food and commercial insulin twice daily such that the hyperglycemia and glucosuria became mild or infrequent. Experimental improvement of the carbohydrate disorder was accompanied by amelioration of hyperlipemia and other clinical signs of deficient insulin activity. By 60 months of diabetes, retinal capillary aneurysms, pericyte ghosts, obliterated vessels, and other microvascular abnormalities typical of diabetes were apparent in each animal of the poor-control group. Better control was found to reduce significantly the incidence and severity of microvascular lesions. The data suggest that the mechanism responsible for diabetic retinopathy is initiated as a result of deficient insulin activity and that the development of the microvascular complications of diabetes are preventable and may be inhibited by careful control of the metabolic disorder.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885298     DOI: 10.2337/diab.26.8.760

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  69 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Controlling blood sugars.

Authors:  A Mehta; I Matwijiw
Journal:  Can Fam Physician       Date:  1985-07       Impact factor: 3.275

3.  Do dogs develop autoimmune diabetes?

Authors:  Edwin A M Gale
Journal:  Diabetologia       Date:  2005-10       Impact factor: 10.122

4.  Hyperglycemia and the pathogenesis of diabetic retinopathy.

Authors:  G L King
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

Review 5.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

6.  Diabetes of 5 years duration does not lead to photoreceptor degeneration in the canine non-tapetal inferior-nasal retina.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Exp Eye Res       Date:  2017-07-19       Impact factor: 3.467

7.  Diabetic control with gliquidone--a short acting sulphonylurea.

Authors:  L J Borthwick; S Wilson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Are the 'second generation' oral hypoglycemic agents really different?

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

9.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics.

Authors:  O A el Haddad; M K Saad
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters.

Authors:  A R Diani; T Peterson; G A Sawada; B M Wyse; M C Blanks; G C Gerritsen; G Terenghi; I M Varndell; J M Polak; M A Blank
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.